NCT05634369 · Interventional trial
A Multi-Institution Study of TGFβ Imprinted, Ex Vivo Expanded Universal Donor NK Cell Infusions as Adoptive Immunotherapy in Combination With Gemcitabine and Docetaxel in Patients With Relapsed or Refractory Pediatric Bone and Soft Tissue
Overall registry status Recruiting
Phase 1 · Phase 2
Conditions Pediatric Sarcoma, Refractory, Pediatric Sarcoma, Relapsed
Delaware Valley sites
- Children's Hospital of Philadelphia · Philadelphia, PA · Philadelphia County · Recruiting
First posted
Registry updated
Added to the directory